Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG

RICE

RICE treatment: Rituximab by intravenous infusion over 6-8 hours on day 1, Eptoposide by intravenous infusion over 2 hours on day 3-5, a 1-hour infusion of Carboplatin on day 4 and a 24-hour infusion of Ifosfamide on day 4, each cycle is 14 days (2 weeks). Patients will receive 3 cycles of RICE treatment.

DRUG

GaRD Treatment

After RICE treatment, patients will have gallium nitrate IV through a vein continuously over a 7 day period. Patients will also receive rituximab by intravenous infusion over a 3-6 hour period on day 1 of each cycle. Dexamethasone will be given as pills to be taken for 4 days in a row on the first 4 days of each cycle. The length of each cycle is 21 days (3 weeks). All patients will have 2 cycles of GaRD.

Trial Locations (1)

60153

Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center, Maywood

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genta Incorporated

INDUSTRY

lead

Loyola University

OTHER